B. Conte-Devolx

Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study

A. Loundou, P. Auquier, O. Mundler, 2009, Clinical endocrinology.

Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawal.

P. Auquier, O. Mundler, F. Sebag, 2010, The Journal of clinical endocrinology and metabolism.

MANAGEMENT OF ENDOCRINE DISEASE: Outcome of adrenal sparing surgery in heritable pheochromocytoma.

F. Castinetti, M. K. Walz, David Taïeb, 2016, European journal of endocrinology.

Sporadic medullary microcarcinoma of the thyroid: a retrospective analysis of eighty cases.

B. Franc, P. Lecomte, O. Chabre, 1998, Thyroid : official journal of the American Thyroid Association.

Quality of life in patients at risk of medullary thyroid carcinoma and followed by a comprehensive medical network: trends for future evaluations.

N. Chau, M. Schlumberger, V. Trillet-lenoir, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

2012 European Thyroid Association Guidelines for Genetic Testing and Its Clinical Consequences in Medullary Thyroid Cancer

M. Alevizaki, R. Elisei, K. Frank‐Raue, 2012, European Thyroid Journal.

Psychosocial impact of genetic testing in familial medullary-thyroid carcinoma: a multicentric pilot-evaluation.

M. Schlumberger, V. Trillet-lenoir, G. Freyer, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.